| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-05 |
| mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.003 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |